Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma

Journal of Clinical Investigation

Volumn 103, Issue 3, 1999, Pages 341-345

  Tanaka, Shinji ^a   Mori, Masaki ^a   Sakamoto, Yoshihiro ^b   Makuuchi, Masatoshi ^b   Sugimachi, Keizo ^c   Wands, Jack R ^d  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; LIGAND; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; ENZYME ACTIVITY; GENE AMPLIFICATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; LIVER CELL CARCINOMA; MOLECULAR CLONING; MULTIGENE FAMILY; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032939205     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4891     Document Type: Article

References (21)

1. Hanahan, D., and Folkman, J. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:353-364.
2. Beck, L., Jr., and D'Amore, P.A. 1997. Vascular development: cellular and molecular regulation. FASEB J. 11:365-373.
3. Davis, S., et al. 1996. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell. 87:1161-1169.
4. Maisonpierre, P.C, et al. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 277:55-60.
5. Runting, A.S., Stacker, S.A., and Wilks, A.F. 1993. Tie2, a putative protein tyrosine kinase from a new class of cell surface receptor. Growth Factors. 9:99-105.
6. Dumont, D.J., Gradwohl, G.J., Fong, G.H., Auerbach, R., and Breitman, M.L. 1993. The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors. Oncogene. 8:1293-1301.
7. Vikkula, M., et al. 1996. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell. 87:1181-1190.
8. Dumont, D.J., et al. 1994. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8:1897-1909.
9. Sato, T.N., et al. 1995. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 376:70-74.
10. Liver Cancer Study Group of Japan. 1990. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann. Surg. 211:277-287.
11. Tanaka, S., et al. 1998. A novel frizzled gene identified in human esophageal carcinoma mediates APC/β-catenin signals. Proc. Natl. Acad. Sci. USA. 95:10164-10169.
12. Tanaka, S., and Wands, J.R. 1996. A carboxy-terminal truncated IRS-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype. J. Clin. Invest. 98:2100-2108.
13. Artega, C.L., et al. 1993. Anti-transforming growth factor (TGF)-β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. J. Clin. Invest. 92:2569-2576.
14. Moradpour, D., and Wands, J.R. 1996. Hepatic incogenesis, IVD. Tumors of the liver. In Hepatology: a textbook of liver disease. Volume 2. 3rd ed. W.B. Saunders. Philadelphia, PA. 1490-1512.
15. Suri, C., et al. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 87:1171-1180.
16. Folkman, J., and D'Amore, P.A. 1996. Blood vessel formation: what is its molecular basis? Cell. 87:1153-1155.
17. Hanahan, D. 1997. Signaling vascular morphogenesis and maintenance. Science. 277:48-50.
18. Huang, L., Turck, C.W., Rao, P., and Peters, K.G. 1995. GRB2 and SH-PTP2: potentially important endothelial signaling molecules down-stream of the TEK/TIE2 receptor tyrosine kinase. Oncogene. 11:2097-2103.
19. Jones, N., and Dumont, D.J. 1998. The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R. Oncogene 17:1097-1108.
20. Kontos, C.D., et al. 1998. Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol. Cell. Biol. 18:4131-4140.
21. Fidler, I.J., and Ellis, L.M. 1994. The implications of angiogenesis for the biology and therapy of cancer. Cell. 79:185-188.